Smart Cells
Smart Cells is a UK private umbilical cord blood and tissue stem cell bank serving expectant parents, cryogenically storing neonatal stem cells for potential future medical use as the UK arm of FamiCord Group.
- Company typePrivate
- Founded2001
- HeadquartersWest Drayton, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Smart Cells does
Smart Cells International Ltd. is a UK-based private umbilical cord blood and tissue stem cell banking service, founded in 2001 as the country's first cord blood bank and currently operating as a subsidiary of FamiCord Group (parent: PBKM, Europe's largest stem cell bank network). The company collects, processes, and cryogenically stores neonatal stem cells at a purpose-built laboratory near London Heathrow Airport, using vapour phase nitrogen storage below -170°C and sterile processing aligned with European GMP Annex 1, NetCord-FACT, and JACIE standards under an HTA licence. Its core products are cord blood stem cell storage and cord tissue stem cell storage (mesenchymal cells from Wharton's jelly); an optional Neuro-Assistance Package coordinates potential autologous administration for children diagnosed with cerebral palsy or autism spectrum disorders.
The business model is direct-to-consumer, targeting expectant parents through educational content marketing, social media (Facebook, Instagram, LinkedIn, X, YouTube), email nurture, baby shows, and structured healthcare-professional referral partnerships with midwives, obstetricians, consultants, and 200+ NHS and private maternity hospitals across the UK. Revenue is generated via an upfront booking fee (starting at £325), a processing and storage fee due after the storage date, and either a recurring annual subscription (CPI-indexed) or a one-time prepaid multi-year plan; an Exit Fee applies for early termination within 10 years. Customers are acquired online, by phone, or in-hospital, and collection kits (e.g., the NanoCool temperature-monitored system) are dispatched for birthing-day retrieval.
As part of FamiCord Group, Smart Cells benefits from group-level scale (500,000+ families served, 1,000,000+ units stored, 240+ transplants, 7,500+ patients treated, 1,500+ collaborating hospitals across Europe). Disclosed UK leadership is limited: CEO Shamshad Ahmed and Scientific Director Dr Ann Smith are named, with no public executive bench beyond these roles. Revenue, funding history, and headcount beyond a stated 11–50 employee range are not publicly disclosed.
Smart Cells firmographics
Firmographics- Name
- Smart Cells
- Legal name
- Smart Cells International Ltd.
- Website
- https://smartcells.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Smart Cells is a UK private umbilical cord blood and tissue stem cell bank serving expectant parents, cryogenically storing neonatal stem cells for potential future medical use as the UK arm of FamiCord Group.
- Ownership category
- akta.pro rank
Smart Cells industry classification
Industry- Product category
- Cord Blood Banking
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
Keywords
Where Smart Cells is headquartered
LocationHeadquarters
- HQ city
- West Drayton
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Smart Cells business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Cord Blood Storage Services: Annual subscription or prepaid plans for umbilical cord blood and tissue stem cell storage services. Customers pay booking fees, processing fees, and recurring annual storage fees.
- Cord Tissue Storage: Storage services for umbilical cord tissue containing mesenchymal stem cells from Wharton's jelly layer, offered as add-on to cord blood storage.
- Neuro-Assistance Package: Optional coordination service for potential autologous administration of stem cells for children diagnosed with cerebral palsy or autism spectrum disorders.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Hybrid | Annual | Affordable Package - Book now for just £325 |
| One time/ perpetual license | Multi-year contract | Prepaid Plan |
| Subscription | Annual | Subscription Plan |
| Unit Pricing | Annual | Twins Discount |
| Other | Pay-as-you-go | Refer a Friend Reward |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels11 records
Smart Cells product offering
Product offeringCore offering
Smart Cells collects, processes, and cryogenically stores umbilical cord blood and cord tissue stem cells from newborns for family-directed future therapeutic use. Customers purchase a collection kit, the kit is used at the birth by a trained phlebotomist, samples are couriered to Smart Cells' UK laboratory for processing and volume reduction, and the stem cells are stored in vapour-phase nitrogen below -170°C for up to 50 years. Optional add-ons include the exclusive Neuro package (providing access to Duke University cerebral palsy trials) and RNA/DNA extraction.
Product overview
Smart Cells is a private cord blood and tissue stem cell banking service, part of the FamiCord Group (Europe's largest stem cell bank). The core offering consists of umbilical cord blood stem cell storage and cord tissue stem cell storage services. The company processes and cryogenically stores samples at a facility near London Heathrow. Optional add-on services include the Neuro-Assistance Package for potential experimental treatments of cerebral palsy or autism, a Collection Kit with temperature-monitored transit, a Refer a Friend referral program, and a free downloadable parent guide. Storage is available under Prepaid or Subscription payment plans.
Differentiator
Problem solved
Functional benefit
Products and services
- Cord Blood Stem Cell Storage Long-term storage of umbilical cord blood stem cells for expectant parents in the UK. The service includes a collection kit, professional collection at birth, courier transport, volume-reduction processing in a UK lab, and continuous cryogenic storage.
- Cord Tissue Stem Cell Storage Storage of stem cells extracted from umbilical cord tissue (Wharton's jelly), capturing mesenchymal cells with regenerative medicine applications. Kit, processing and long-term storage are included.
- Neuro Package Exclusive optional add-on to Smart Cells' storage services that provides enrolled children with access to Duke University's umbilical cord clinical trials for conditions such as cerebral palsy.
- Umbilical Cord Collection Collection and storage of the entire umbilical cord for stem cell extraction, separate from cord blood and cord tissue offerings.
- RNA and DNA Extraction Optional service extracting RNA and DNA from stored cord tissue samples for future genetic or diagnostic use.
Quantifiable outcome
- Stem cells can treat up to 80 severe diseases including blood cancers, bone marrow disorders, immune deficiencies, and genetic disorders
- +2 more outcomes
Companies that use Smart Cells
Customer profileNamed customers4 records
Segments1 record
Ideal customer profiles1 record
Smart Cells technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Smart Cells partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- FamiCord GroupcoreSmart Cells is part of the FamiCord Group, Europe's largest stem cell bank serving 500,000+ families. The group operates across multiple European countries with shared resources, technology, and expertise in cord blood and tissue banking.
- PBKM (Polski Bank Komorek Macierzystych)corePBKM is the parent company of FamiCord Group and a leading provider of mesenchymal stem cells from cord tissue Wharton’s jelly. By March 2021, PBKM had supplied MSCs for treatment of 1687 patients on registered clinical trials.
- UK Hospitals (200+ NHS and Private)coreSmart Cells provides cord blood and tissue stem cell collection services across over 200 NHS hospitals and private maternity hospitals in the UK, including major London private maternity units.
Scale indicators6 records
Recent moves5 records
Expansion highlights4 records
Smart Cells competitors and assessment
Company assessmentDirect peers
- Cells4Life: UK-based private umbilical cord blood and tissue stem cell bank offering comparable consumer cord blood and cord tissue storage services, with overlapping NHS and private maternity hospital coverage. The most direct UK competitor to Smart Cells on product, customer, and channel.
- Future Health Biobank: UK-based private stem cell bank storing cord blood, cord tissue, and dental pulp stem cells, with multi-country European operations. Directly comparable DTC cord blood banking proposition aimed at expectant parents in the UK and Europe.
- Virgin Health Bank: UK-based private umbilical cord blood stem cell bank, one of the longest-established UK entrants. Competes head-to-head with Smart Cells for the same expectant parent segment in the UK, with similar collection-and-storage value proposition.
Broad incumbents
- Cryo-Cell International: US-listed (public) cord blood bank and one of the world's largest private family cord blood banks. Comparable consumer cord blood and tissue storage services with a longer public-company operating history and broader international footprint than Smart Cells.
- ViaCord: US-based private cord blood and cord tissue banking service (part of Revvity/PerkinElmer group). Offers the same expectant-parent DTC cord blood and tissue storage proposition as Smart Cells, with broader corporate parentage and US scale.
- Cord Blood Registry (CBR): Largest US private family cord blood bank, with over 1 million stored samples, serving the same expectant-parent use case as Smart Cells. Operates at significantly greater scale in North America and is a benchmark global incumbent in private cord blood banking.
Others
- PBKM (Polski Bank Komórek Macierzystych): Polish parent company of FamiCord Group and direct corporate parent of Smart Cells. Operates cord blood and MSC banking services across Poland and Europe; included as the upstream parent and source of MSC clinical pipeline rather than as a direct market competitor in the UK.
Emerging players
- Sevibe Cells: Spain-based FamiCord Group affiliate offering private cord blood and tissue storage across Iberia. Comparable product set to Smart Cells but primarily serving Spanish and Portuguese markets, representing a sister-brand rather than UK head-to-head competitor.
- Precious Cells International: UK-based private stem cell bank offering cord blood and tissue storage to expectant parents. Smaller and more niche than Smart Cells, but operates in the same UK DTC market and competes for the same hospital distribution and consumer demand.
Regional players
- Crioestaminal: Portugal-based private cord blood bank, also part of the FamiCord Group network. Offers directly comparable cord blood and tissue storage services to Smart Cells but is geographically focused on Portugal and selected Lusophone markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Smart Cells social profiles
Digital presenceSmart Cells compliance and trust
Trust signalCompliance5 records
Smart Cells financial estimates
Financial estimateRevenue estimate
Valuation estimate
Smart Cells leadership team
Management profileNumber of profiles
Profiles2 records
Smart Cells funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Smart Cells M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Smart Cells
What does Smart Cells do?
Smart Cells collects, processes, and cryogenically stores umbilical cord blood and cord tissue stem cells from newborns for family-directed future therapeutic use. Customers purchase a collection kit, the kit is used at the birth by a trained phlebotomist, samples are couriered to Smart Cells' UK laboratory for processing and volume reduction, and the stem cells are stored in vapour-phase nitrogen below -170°C for up to 50 years. Optional add-ons include the exclusive Neuro package (providing access to Duke University cerebral palsy trials) and RNA/DNA extraction.
Is Smart Cells a public or private company?
Smart Cells is a private company. It is classified as corporate owned and is currently operating.
When was Smart Cells founded?
Smart Cells was founded in 2001. It employs 11 to 50 people.
Where is Smart Cells based?
Smart Cells is headquartered in West Drayton, United Kingdom, in the Europe region.
How does Smart Cells make money?
Three revenue lines are on record. Cord Blood Storage Services are the primary driver. The others are cord Tissue Storage and neuro-Assistance Package.
Who are Smart Cells's main competitors?
Direct peers on record are Cells4Life, Future Health Biobank and Virgin Health Bank. Broad incumbents are Cryo-Cell International, ViaCord and Cord Blood Registry (CBR). PBKM (Polski Bank Komórek Macierzystych) is listed as an others. Emerging players are Sevibe Cells and Precious Cells International. Crioestaminal is listed as a regional player.
Does Smart Cells have an API?
No public API is recorded for Smart Cells.
What industry is Smart Cells in?
Smart Cells's product category is Cord Blood Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 2836.